Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6380990 | 0.88 | — | — | |
| SCHEMBL5074933 | 0.79 | — | — | |
| SCHEMBL5073165 | 0.68 | ADRB2 (0.32) | ADRB2ADRB1ADRB3CA12CA1 | |
| SCHEMBL5079100 | 0.68 | NOS1 (0.31) | — | |
| SCHEMBL17363976 | 0.65 | ALDH1A1 (0.41) | ADRB2ADRB1ADRB3CA1CA2 | |
| SCHEMBL10828141 | 0.65 | FDPS (0.36) | — | |
| SCHEMBL3165873 | 0.65 | FDPS (0.36) | — | |
| SCHEMBL19244068 | 0.65 | FDPS (0.36) | — | |
| SCHEMBL434225 | 0.65 | — | — | |
| SCHEMBL31195333 | 0.65 | TSHR (0.40) | ADRB2ADRB1ADRB3CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1973923-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007083395-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2007-07-26 | — | — | WO | disclosed |